UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

 

Date of Report (Date of earliest event reported)		April 4, 2017
SANUWAVE Health, Inc.
(Exact name of registrant as specified in its charter)

 

Nevada	000-52985		20-1176000
(State or other jurisdiction of incorporation)	(Commission File Number)		(IRS Employer Identification No.)

 

3360 Martin Farm Road, Suite 100, Suwanee, Georgia			30024
(Address of principal executive offices)			(Zip Code)

 

Registrant’s telephone number, including area code

(770) 419-7525

 

N/A

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

Item 2.02          Results of Operations and Financial Condition.

 

On April 4, 2017, SANUWAVE Health, Inc., a Nevada Corporation (the "Company"), announced its financial results for the year ended December 31, 2016 and provided a business update. A copy of the related press release is furnished as Exhibit 99.1 to this Form 8-K.

 

The information in this Item 2.02 of this Current Report on Form 8-K and the exhibits attached hereto shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

 

Item 7.01          Regulation FD Disclosure

 

The Company hosted a conference call with investors on April 4, 2017 at 10 a.m., Eastern Time, to discuss the financial results for the year ended December 31, 2016 and provide a business update. A copy of management’s prepared remarks is furnished as Exhibit 99.2.

 

The information in this Item 7.01 of this Current Report on Form 8-K and the exhibit attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

 

Item 9.01          Financial Statements and Exhibits.

 

	(d)  Exhibits.
	Exhibit No.	Description
	99.1	Press release, dated April 4, 2017, issued by SANUWAVE Health, Inc., titled “SANUWAVE Health reports record revenue in 2016 and provides a business update.”
	99.2	Management’s prepared remarks for the April 4, 2014, SANUWAVE Health, Inc. conference call to discuss the year ended December 31, 2016 financial results and provide a business update.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

	SANUWAVE HEALTH, INC.
Dated: April 6, 2016	By:	/s/ Lisa E. Sundstrom
	Name:  Lisa E. Sundstrom
	Title:    Controller and Chief Financial Officer

 

 

EXHIBIT INDEX

 

Exhibit No.		Description
99.1			Press release, dated April 4, 2017, issued by SANUWAVE Health, Inc., titled “SANUWAVE Health reports record revenue in 2016 and provides a business update.”
99.2			Management’s prepared remarks for the April 4, 2014, SANUWAVE Health, Inc. conference call to discuss the year ended December 31, 2016 financial results and provide a business update.